<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="10.17917/V9AP-D094 " scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><h2>NCL Method ITA-1: Analysis of Hemolytic Properties of Nanoparticles</h2><hr><p>This document describes a protocol for quantitative colorimetric determination of total hemoglobin in whole blood (TBH) and plasma free hemoglobin (PFH). An increase in the plasma free hemoglobin is indicative of erythrocyte damage by the test material (a positive control substance or a nanoparticle).</p><h3>File name: protocols/20240410_18-57-43-564_NCL_Method_ITA-1.pdf</h3><h3>DOI: <a href = http://dx.doi.org/10.17917/V9AP-D094 >http://dx.doi.org/10.17917/V9AP-D094 </a></h3<br><h3>Resource Type:  Protocol</h3><h3>Data Access: <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a></h3></body></html>